NVOS — Novo Integrated Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $1.18m
- $4.20m
- $13.29m
- 21
- 82
- 19
- 34
Annual cashflow statement for Novo Integrated Sciences, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.92 | -4.47 | -33 | -13.3 | -16.1 |
| Depreciation | |||||
| Non-Cash Items | 3.91 | 1.75 | 24.7 | 8.26 | 10 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.871 | -0.029 | -0.523 | 0.461 | -1.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.442 | -1.02 | -5.88 | -2.24 | -5.07 |
| Capital Expenditures | -0.012 | -0.256 | -0.19 | -0.049 | -0.005 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.669 | 3.26 | 0.354 | 0 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.657 | 3 | 0.163 | -0.049 | -0.005 |
| Financing Cash Flow Items | -0.466 | 0 | 15.3 | 1.29 | 8.65 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.272 | 4.32 | -0.427 | 0.764 | 4.99 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.016 | 6.23 | -6.11 | -1.76 | 0.428 |